Veradigm®

Quick question for RWE and HEOR teams: When you design a real-world study, how are you capturing the patient's perspective? Not the diagnosis. Not the prescription. Not the lab value. The experience. Satisfaction with treatment. Symptom burden. Quality of life. Adherence intent. These dimensions increasingly matter to regulators, payers, and the prescribers you're trying to reach — and they don't live in any clinical dataset. Curious how others are thinking about this. And happy to share how Veradigm's PRO Surveys solution is helping life sciences teams close the gap. Drop your approach in the comments — or reach out directly. #PatientVoice #RWE #HealthcareData #LifeSciences #RealWorldEvidence #HEOR #Veradigm

A brief survey completed in under a minute can generate evidence that a years-long retrospective study cannot. That's not a knock on retrospective research — it's a recognition that patient experience data requires a different tool. Symptom burden. Treatment satisfaction. Quality of life. Adherence intent. These dimensions don't live in EHR records or claims databases. They live with the patient. The key is building an infrastructure that reaches patients at scale, through channels they trust, and links their responses to the clinical data that contextualizes them. That's what Veradigm's PRO Surveys platform is designed to do. #PatientVoice #RWE #HealthcareData #LifeSciences #RealWorldEvidence #HEOR #Veradigm

~16% response rate. ~1-minute average completion time. No compensation. That's what Veradigm achieved on a recent PRO survey study in dry eye disease — roughly 8x the industry standard for digital surveys. The reason: patients received the survey through FollowMyHealth®, a platform they already use and trust. Not cold outreach. Not an unfamiliar third-party tool. And when we validated patient-reported refill intent against actual pharmacy claims? They correlated closely. Patient intent predicted real-world behavior. That's the power of PRO data integrated with clinical records.

Get the latest jobs and industry news

No demo. No forty-slide deck. Two practice leaders talk through what is actually working on denials, and what still keeps them up at night.